Similar articles

• Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.

  Scordo MG, Spina E, Facciolà G, Avenoso A, Johansson I, Dahl ML. Scordo MG, et al. Psychopharmacology (Berl). 1999 Dec;147(3):300-5. doi: 10.1007/s002130051171. Psychopharmacology (Berl). 1999. PMID: 10639689 Clinical Trial.
• Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4.

  Fang J, Bourin M, Baker GB. Fang J, et al. Naunyn Schmiedebergs Arch Pharmacol. 1999 Feb;359(2):147-51. doi: 10.1007/pl00005334. Naunyn Schmiedebergs Arch Pharmacol. 1999. PMID: 10048600
• A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.

  Bork JA, Rogers T, Wedlund PJ, de Leon J. Bork JA, et al. J Clin Psychiatry. 1999 Jul;60(7):469-76. J Clin Psychiatry. 1999. PMID: 10453802
• The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions.

  Berecz R, Dorado P, De La Rubia A, Cáceres MC, Degrell I, LLerena A. Berecz R, et al. Curr Drug Targets. 2004 Aug;5(6):573-9. doi: 10.2174/1389450043345263. Curr Drug Targets. 2004. PMID: 15270204 Review.
• The pharmacokinetics of paliperidone versus risperidone.

  de Leon J, Wynn G, Sandson NB. de Leon J, et al. Psychosomatics. 2010 Jan-Feb;51(1):80-8. doi: 10.1176/appi.psy.51.1.80. Psychosomatics. 2010. PMID: 20118446 Review.